Tag: Richard Mulligan
-
Science & Tech
‘Any patient with any disease’
Developed through Harvard’s Blavatnik Biomedical Accelerator, an innovative immune-silent stem cell technology could lead to novel cell therapies to treat “any patient with any disease.”
-
Health
Sickle cell disease cured in mouse model
Sickle cell disease is a blood disorder caused by a single mutation in the beta-globin gene that results in the substitution of one amino acid. This small error is enough…